ATE229799T1 - Verwendung von phospholipiden zur herstellung eines arzneimittels zur behandlung von asthma - Google Patents

Verwendung von phospholipiden zur herstellung eines arzneimittels zur behandlung von asthma

Info

Publication number
ATE229799T1
ATE229799T1 AT98955794T AT98955794T ATE229799T1 AT E229799 T1 ATE229799 T1 AT E229799T1 AT 98955794 T AT98955794 T AT 98955794T AT 98955794 T AT98955794 T AT 98955794T AT E229799 T1 ATE229799 T1 AT E229799T1
Authority
AT
Austria
Prior art keywords
asthma
phospholipides
treatment
production
medicinal product
Prior art date
Application number
AT98955794T
Other languages
English (en)
Inventor
Brian Andrew Hills
Derek Alan Woodcock
Original Assignee
Britannia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26312708&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE229799(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9725640.8A external-priority patent/GB9725640D0/en
Priority claimed from GBGB9727276.9A external-priority patent/GB9727276D0/en
Application filed by Britannia Pharmaceuticals Ltd filed Critical Britannia Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE229799T1 publication Critical patent/ATE229799T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/002—Particle size control by flow deviation causing inertial separation of transported particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8218—Gas operated
    • A61M2205/8225—Gas operated using incorporated gas cartridges for the driving gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98955794T 1997-12-03 1998-11-26 Verwendung von phospholipiden zur herstellung eines arzneimittels zur behandlung von asthma ATE229799T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9725640.8A GB9725640D0 (en) 1997-12-03 1997-12-03 Use of surface-active phospholipids in asthma treatment
GBGB9727276.9A GB9727276D0 (en) 1997-12-24 1997-12-24 Improvements in medicaments for asthma treatment
PCT/GB1998/003543 WO1999027920A2 (en) 1997-12-03 1998-11-26 Use of phospholipids for the manufacture of a medicament for the treatment of asthma

Publications (1)

Publication Number Publication Date
ATE229799T1 true ATE229799T1 (de) 2003-01-15

Family

ID=26312708

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98955794T ATE229799T1 (de) 1997-12-03 1998-11-26 Verwendung von phospholipiden zur herstellung eines arzneimittels zur behandlung von asthma

Country Status (8)

Country Link
US (3) US6482391B1 (de)
EP (1) EP1082108B1 (de)
AT (1) ATE229799T1 (de)
AU (1) AU1251999A (de)
DE (1) DE69810355T2 (de)
DK (1) DK1082108T3 (de)
ES (1) ES2189269T3 (de)
WO (1) WO1999027920A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE229799T1 (de) 1997-12-03 2003-01-15 Britannia Pharmaceuticals Ltd Verwendung von phospholipiden zur herstellung eines arzneimittels zur behandlung von asthma
GB9912639D0 (en) * 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
WO2000030654A1 (en) * 1998-11-26 2000-06-02 Britannia Pharmaceuticals Limited Anti-asthmatic combinations comprising surface active phospholipids
GB9908921D0 (en) * 1999-04-19 1999-06-16 Britannia Pharmaceuticals Ltd Spray dispenser for opiod antagonists
GB0026239D0 (en) * 2000-10-26 2000-12-13 Britannia Pharmaceuticals Ltd Surface active lipids in treatment of wet lung
EP2168571B1 (de) * 2000-11-30 2018-08-22 Vectura Limited Inhalierbare Arzneizusammensetzung
AU2002255181A1 (en) * 2001-05-21 2002-12-03 Britannia Pharmaceuticals Limited Use of phospholipids in the treatment of degenerative lung disease such as copd or cystic fibrosis and to enhance delivery of drugs
GB0117911D0 (en) * 2001-07-23 2001-09-12 Britannia Pharmaceuticals Ltd Pulmonary humectant
GB0200704D0 (en) * 2002-01-14 2002-02-27 Britannia Pharmaceuticals Ltd Use of phospholipids in peritoneal dialysis
GB0201028D0 (en) * 2002-01-17 2002-03-06 Britannia Pharmaceuticals Ltd Prevention of infectious diseases
GB0313604D0 (en) * 2003-06-12 2003-07-16 Britannia Pharmaceuticals Ltd Delivery device for powdered medicament
WO2005099718A1 (en) * 2004-04-19 2005-10-27 Centre National De La Recherche Scientifique (C.N.R.S.) Lung surfactant supplements
KR100891595B1 (ko) * 2005-02-28 2009-04-03 주식회사 케이티앤지 혈액 단백질의 삼출을 감소시키는 조성물
GB0510463D0 (en) * 2005-05-23 2005-06-29 Britania Pharmaceuticals Ltd Improvements in or relating to organic materials
FR2889957B1 (fr) * 2005-09-01 2008-06-27 Gerard Pieroni Utilisation du dha sous forme de phospholipides pour la preparation d'une composition destinee au traitement de l'insuffisance respiratoire.
US7566743B2 (en) * 2005-11-18 2009-07-28 Mark Glazman System and method for medical treatment
WO2007097502A1 (en) * 2006-02-23 2007-08-30 Kt & G Corporation Composition for reducing the exudation of serum proteins
EP2086617A4 (de) 2006-10-26 2013-11-20 Next Breath Llc Inhalationssystem auf phospholipid-basis
US20090110679A1 (en) * 2007-07-13 2009-04-30 Luk-Chiu Li Methods and compositions for pulmonary administration of a TNFa inhibitor
US20110244058A1 (en) * 2008-08-01 2011-10-06 Gerald Horn Compositions and methods for treatment of pulmonary diseases and conditions
US9603907B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Dry powder formulations of dNase I
US20150174158A1 (en) 2012-03-07 2015-06-25 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
WO2013152044A1 (en) * 2012-04-02 2013-10-10 The Board Of Regents Of The University Of Texas System Use of pc-nsaids to treat and/or prevent pulmonary inflammation
US20170304459A1 (en) 2014-10-10 2017-10-26 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide
WO2017132601A1 (en) * 2016-01-29 2017-08-03 Mannkind Corporation Dry powder inhaler
CN110300605A (zh) * 2016-12-16 2019-10-01 慕斯迪克香水公司 分配香料调和物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58164513A (ja) 1982-03-25 1983-09-29 Teijin Ltd 肺表面活性物質及びその調製法
DE3229179C2 (de) 1982-08-05 1986-04-17 A. Nattermann & Cie GmbH, 5000 Köln Lungensurfactant
DE3686025T2 (de) * 1985-05-22 1993-01-07 Liposome Technology Inc Verfahren und system zum einatmen von liposomen.
US6013619A (en) * 1988-01-06 2000-01-11 The Scripps Research Institute Pulmonary surfactants and therapeutic uses, including pulmonary lavage
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
AU660612B2 (en) * 1990-05-18 1995-07-06 Mitsubishi-Tokyo Pharmaceuticals, Inc. Remedy for asthma
GB9011588D0 (en) * 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
FR2721521B1 (fr) * 1994-06-27 1996-12-13 Commissariat Energie Atomique Dispositif microdoseur pulvérisateur automatique de médicament et ensemble doseur intelligent utilisant ce dispositif.
WO1997029738A1 (en) * 1996-02-16 1997-08-21 The Administrators Of The Tulane Educational Fund Methods and compositions for treating eustachian tube dysfunction by inhalation
US6120751A (en) * 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US5925334A (en) * 1997-08-27 1999-07-20 Rubin; Bruce K. Use of surface active agents to promote mucus clearance
ATE229799T1 (de) 1997-12-03 2003-01-15 Britannia Pharmaceuticals Ltd Verwendung von phospholipiden zur herstellung eines arzneimittels zur behandlung von asthma

Also Published As

Publication number Publication date
DE69810355T2 (de) 2003-10-30
US6482391B1 (en) 2002-11-19
WO1999027920A2 (en) 1999-06-10
EP1082108A2 (de) 2001-03-14
US20030044357A1 (en) 2003-03-06
AU1251999A (en) 1999-06-16
US7473416B2 (en) 2009-01-06
ES2189269T3 (es) 2003-07-01
EP1082108B1 (de) 2002-12-18
US20050063910A1 (en) 2005-03-24
DK1082108T3 (da) 2003-01-20
WO1999027920A3 (en) 1999-09-10
DE69810355D1 (de) 2003-01-30

Similar Documents

Publication Publication Date Title
ATE229799T1 (de) Verwendung von phospholipiden zur herstellung eines arzneimittels zur behandlung von asthma
PT1061901E (pt) Inalador de nicotina
EA200100338A1 (ru) Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента
DK0799024T3 (da) Farmaceutisk aerosol indeholdende mindst en sukker
ATE216243T1 (de) Verwendung von mometasone-furoat zur behandlung von luftweg- und lungenerkrankungen
ATE216575T1 (de) Treibgasmischung für eine aerosolzubereitung
DE69628160D1 (de) Herstellung von natrium chlorid aerosol formulierungen
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE69840495D1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
RU94030722A (ru) Аэрозольная фармацевтическая композиция, лекарственное средство с модифицированной поверхностью, баллон для доставки фармацевтической композиции, ингалятор, способ лечения респираторных заболеваний
ATE250420T1 (de) Verwendung von uridin-triphosphat verwandte verbidungen zur prävention und behandlung von pneumonie in immobilisieren patienten
KR20100015802A (ko) 개선된 특성을 가지는 재구성된 계면활성제
MXPA05009629A (es) Composiciones que contienen trospio.
EE04038B1 (et) Inhaleeritav formoterooli sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml, meetod selle valmistamiseks ning kasutamine
DE69821655D1 (de) Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen
DE69811407D1 (de) Verwendung eines oberflächenaktiven mittels zur herstellung eines arzneimittels zur behandlung von erkrankungen des mittelohrs
ATE263552T1 (de) Neuartige formulierung zur inhalation mit einer bulkdichte zwischen 0.28 und 0.38 g/ml, mit terbutalinsulphat, verfahren zur herstellung der formulierung sowie anwendung derselben
DE69021257D1 (de) Verwendung von IFN-gamma zur Herstellung einer pharmazeutischen Zusammensetzung für die Behandlung von ATL.
SE9400241L (sv) Sätt, användning och beredning av aerosol för läkemedelsdistribution innehållande helium och/eller neon
HU895932D0 (en) Process for production of medical compositions for treatment of acute, chronicle and obstructive deseases of respiratory organs containing as active substance derivatives of dibenzazepinon
Ahmed Histological and histomorphometric evaluation of anterior part of rats tongue exposed to passive cigarette smoking
Nouvet et al. Respiratory Signs of Flax Strippers.
Donald et al. Artificial Respiration
CN1036127A (zh) 含有珊瑚姜成分的药物烟
ATE318612T1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1082108

Country of ref document: EP